Welcome to another episode of "The Future of the Future" podcast.

Today, we have the privilege of hosting Carter Cliff, the CEO of Papillon Therapeutics, a pioneering company advancing genetic medicines for life-threatening conditions.

In this episode, we'll delve into the realm of cell replacement therapy, a groundbreaking approach in regenerative medicine that involves replacing damaged or dysfunctional cells with healthy ones. This therapeutic strategy holds immense potential for treating various diseases, including certain types of cancer and degenerative disorders.

We'll explore the latest advancements, ethical considerations, and the future trajectory of this promising field.

Join us as we uncover the transformative possibilities of cell replacement therapy with Carter Cliff, whose leadership at Papillon Therapeutics is at the forefront of these medical innovations.